NGNE Neurogene20.42-14.09 (-40.8%)
Premarket Decliner
NGNE Neurogene34.51-4.69-12.0%
Premarket:28.50-6.01 (-17.4%)
Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
Business WireMon, 18-Nov 6:45 AM
NGNE Neurogene39.62-0.38 (-1.0%)